These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2005-001562-13 OXCARBAZEPINE VS PHENYTOIN IN THE TREATMENT OF SEIZURES IN PATIENTS WITH BRAIN TUMORS UNDERGOING NEUROSURGICAL PROCEDURES bad-data
Completed, but no date 2005-006105-40 TREATMENT OF IDIOPATHIC ASTHENOZOOSPERMIE WITH COENZYME Q10. A DOUBLE BLIND CONTROLLED STUDY bad-data
Not reported 2006-001505-28 Randomised, parallel phase IV study on the safety of hymenoptera venom immunotherapy 2008-07-30 due-trials
Not reported 2006-002564-25 A PHASE II MULTICENTER STUDY OF BORTEZOMIB, THALIDOMIDE, PEGHILATED LIPOSOMAL DOXORUBICIN, DEXAMETHASONE (ThaDD-V)IN PATIENTS AFFECTED BY RELAPSED-REFRACTORY MULTIPLE MYELOMA 2009-07-20 due-trials
Not reported 2006-002588-22 A phase II, multicenter study of etoposide, aracytin, dexamethasone and bortezomib in patients affected by relapsed/refractory multiple myeloma previously treated with thalidomide 2008-10-20 due-trials
Ongoing 2006-003957-25 Rare Diseases with microvascular involvement. High Dose Intravenous N-acetylcysteine versus Iloprost for early, rapidly not-yet-due
Ongoing 2006-004016-40 APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER not-yet-due
Ongoing 2006-005757-30 MIRACL IN CABG - Statins in cardiac surgery. Effect of doses on inflammatory response and early results not-yet-due
Ongoing 2007-005322-68 Low-dose oral imatinib in the treatment of scleroderma pulmonary involvement: a phase II pilot study not-yet-due
Ongoing 2008-004996-24 A RANDOMIZED PHASE II STUDY OF TAXOTERE, OXALIPLATIN, CAPECITABINE (TOX) OR EPIDOXORUBICIN, OXALIPLATIN AND CAPECITABINE (EOX) IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC CANC... not-yet-due
Ongoing 2008-005967-33 randomized phase II trial of two different sequences in first line chemotherapy of advanced non small cell lung cancer not-yet-due
Completed, but no date 2009-012317-22 PEDIATRIC BASAL BOLUS THERAPY - Basal-Bolus regimen in the treatment of children with type 1 diabetes bad-data
Other 2009-016902-17 Direct renin inhibitor (aliskiren)and carotid plaques instability markers in hypertensive patients requiring carotid endoarterectomy not-yet-due
Completed, but no date 2009-017412-32 RANDOMISED CONTROLLED TRIAL OF BOTULINUM TOXIN TYPE A AND B EFFICACY IN REDUCING DROOLING IN PARKINSON DISEASE bad-data
Ongoing 2010-020072-33 Bendamustine, Bortezomib and Dexamethasone (BVD) in the treatment of relapsed or refractory Multiple Myeloma not-yet-due
Ongoing 2012-000477-23 A randomized phase II study of FOLFORI plus or not CETUXIMAB in elderly advanced colorectal cancer patients. not-yet-due
Ongoing 2012-004742-16 Evaluation of the risk of nephrotoxicity caused by the intravenous administration of nonionic iodinated contrast media not-yet-due
Ongoing 2013-004596-12 HOME INFUSION THERAPY WITH ILOPROST USING A PORTABLE SYRINGE PUMP FOR THE TREATMENT OF PERIPHERAL ULCERS AND RAYNAUD'S PHENOMENON IN SYSTEMIC SCLEROSIS. not-yet-due